EMD-386088: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation ( |
butyrophenone side-chain patent. |
||
(25 intermediate revisions by 17 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = |
| verifiedrevid = 424722665 |
||
| IUPAC_name |
| IUPAC_name = 5-chloro-2-methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1''H''-indole |
||
| image |
| image = EMD-386088.svg |
||
⚫ | |||
<!--Clinical data--> |
|||
⚫ | |||
| tradename = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| molecular_weight = 245.727 g/mol |
|||
⚫ | |||
<!--Pharmacokinetic data--> |
|||
| bioavailability |
| bioavailability = |
||
| metabolism |
| metabolism = |
||
| elimination_half-life |
| elimination_half-life = |
||
| excretion |
| excretion = |
||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
⚫ | |||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| ChemSpiderID = 8306627 |
|||
<!--Chemical data--> |
|||
⚫ | |||
⚫ | |||
| StdInChI = 1S/C14H15ClN2/c1-9-14(10-4-6-16-7-5-10)12-8-11(15)2-3-13(12)17-9/h2-4,8,16-17H,5-7H2,1H3 |
|||
| StdInChIKey = BPPGPYJBCVXILI-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''EMD- |
'''EMD-386088''' is an [[indole]] derivative which is used in [[scientific research]]. It acts as a [[potency (pharmacology)|potent]] [[5-HT6 receptor|5-HT<sub>6</sub> receptor]] [[partial agonist]], with a [[Dissociation constant|K<sub>i</sub>]] of 1 nM, a significantly higher [[affinity (pharmacology)|affinity]] than older 5-HT<sub>6</sub> agonists such as [[EMDT]], although it possesses moderate affinity for the [[5-HT3 receptor|5-HT<sub>3</sub> receptor]] as well.<ref>{{cite journal | vauthors = Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H | display-authors = 6 | title = 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists | journal = Bioorganic & Medicinal Chemistry Letters | volume = 15 | issue = 19 | pages = 4230–4234 | date = October 2005 | pmid = 16055331 | doi = 10.1016/j.bmcl.2005.06.067 }}</ref> Subsequent research has determined that EMD-386088 is also a [[dopamine reuptake inhibitor]] and that this action is involved in the [[antidepressant]]-like effects of the drug in rodents.<ref name="pmid27106213">{{cite journal | vauthors = Jastrzębska-Więsek M, Siwek A, Partyka A, Antkiewicz-Michaluk L, Michaluk J, Romańska I, Kołaczkowski M, Wesołowska A | display-authors = 6 | title = Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats | journal = Naunyn-Schmiedeberg's Archives of Pharmacology | volume = 389 | issue = 8 | pages = 839–849 | date = August 2016 | pmid = 27106213 | pmc = 4939156 | doi = 10.1007/s00210-016-1245-3 }}</ref> |
||
EMD-386088 can be further reacted with a butyrophenone sidechain.<ref>Genus Possanza, Kurt Freter, & Sven Luttke, {{US patent|3980658}} (1976 to Boehringer Ingelheim GmbH).</ref> |
|||
== See also == |
== See also == |
||
* [[EMDT]] |
* [[EMDT]] |
||
* [[ST-1936]] |
|||
* [[Tepirindole]] |
|||
== References == |
== References == |
||
{{Reflist}} |
{{Reflist}} |
||
{{Dopamine receptor modulators}} |
|||
{{Serotonergics}} |
|||
{{Serotonin receptor modulators}} |
|||
⚫ | |||
[[Category:Dopamine reuptake inhibitors]] |
|||
[[Category:Indoles]] |
[[Category:Indoles]] |
||
[[Category: |
[[Category:Tetrahydropyridines]] |
||
[[Category: |
[[Category:Chloroarenes]] |
||
⚫ | |||
{{Nervous-system-drug-stub}} |